nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ABCB1—ovarian cancer	0.29	1	CbGaD
Trazodone—CYP3A7—Paclitaxel—ovarian cancer	0.0467	0.0991	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0467	0.0991	CbGbCtD
Trazodone—ABCB1—Topotecan—ovarian cancer	0.046	0.0977	CbGbCtD
Trazodone—CYP3A5—Paclitaxel—ovarian cancer	0.035	0.0743	CbGbCtD
Trazodone—CYP3A7—Docetaxel—ovarian cancer	0.0337	0.0716	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0337	0.0716	CbGbCtD
Trazodone—ABCB1—Vinorelbine—ovarian cancer	0.0324	0.0688	CbGbCtD
Trazodone—CYP2D6—Vinorelbine—ovarian cancer	0.0306	0.0649	CbGbCtD
Trazodone—CYP3A4—Topotecan—ovarian cancer	0.0276	0.0585	CbGbCtD
Trazodone—CYP3A5—Docetaxel—ovarian cancer	0.0253	0.0537	CbGbCtD
Trazodone—ABCB1—Paclitaxel—ovarian cancer	0.0228	0.0484	CbGbCtD
Trazodone—CYP3A4—Vinorelbine—ovarian cancer	0.0194	0.0412	CbGbCtD
Trazodone—ABCB1—Docetaxel—ovarian cancer	0.0165	0.035	CbGbCtD
Trazodone—CYP3A4—Paclitaxel—ovarian cancer	0.0137	0.029	CbGbCtD
Trazodone—ABCB1—Doxorubicin—ovarian cancer	0.0123	0.0261	CbGbCtD
Trazodone—CYP2D6—Doxorubicin—ovarian cancer	0.0116	0.0246	CbGbCtD
Trazodone—CYP3A4—Docetaxel—ovarian cancer	0.00987	0.0209	CbGbCtD
Trazodone—CYP3A4—Doxorubicin—ovarian cancer	0.00736	0.0156	CbGbCtD
Trazodone—HTR2A—vein—ovarian cancer	0.00353	0.0948	CbGeAlD
Trazodone—HTR2B—myometrium—ovarian cancer	0.0013	0.0349	CbGeAlD
Trazodone—ORM1—endometrium—ovarian cancer	0.00109	0.0291	CbGeAlD
Trazodone—HTR2B—uterine cervix—ovarian cancer	0.00101	0.0272	CbGeAlD
Trazodone—HTR2B—decidua—ovarian cancer	0.000965	0.0259	CbGeAlD
Trazodone—HTR2B—endometrium—ovarian cancer	0.000916	0.0246	CbGeAlD
Trazodone—ORM1—female reproductive system—ovarian cancer	0.000899	0.0241	CbGeAlD
Trazodone—ORM1—bone marrow—ovarian cancer	0.000849	0.0228	CbGeAlD
Trazodone—HTR2B—uterus—ovarian cancer	0.000844	0.0227	CbGeAlD
Trazodone—ADRA1A—epithelium—ovarian cancer	0.000844	0.0226	CbGeAlD
Trazodone—HRH1—myometrium—ovarian cancer	0.000832	0.0223	CbGeAlD
Trazodone—ADRA2A—myometrium—ovarian cancer	0.000817	0.0219	CbGeAlD
Trazodone—HTR2C—female reproductive system—ovarian cancer	0.000808	0.0217	CbGeAlD
Trazodone—SLC6A4—female reproductive system—ovarian cancer	0.000766	0.0206	CbGeAlD
Trazodone—HTR2B—female reproductive system—ovarian cancer	0.000759	0.0204	CbGeAlD
Trazodone—HTR2B—vagina—ovarian cancer	0.000686	0.0184	CbGeAlD
Trazodone—HTR2A—embryo—ovarian cancer	0.000669	0.0179	CbGeAlD
Trazodone—CYP3A5—uterine cervix—ovarian cancer	0.000667	0.0179	CbGeAlD
Trazodone—HRH1—epithelium—ovarian cancer	0.000653	0.0175	CbGeAlD
Trazodone—HRH1—uterine cervix—ovarian cancer	0.000648	0.0174	CbGeAlD
Trazodone—ADRA2A—uterine cervix—ovarian cancer	0.000636	0.0171	CbGeAlD
Trazodone—HRH1—decidua—ovarian cancer	0.000617	0.0166	CbGeAlD
Trazodone—ADRA2A—decidua—ovarian cancer	0.000606	0.0163	CbGeAlD
Trazodone—HRH1—endometrium—ovarian cancer	0.000586	0.0157	CbGeAlD
Trazodone—ADRA2A—endometrium—ovarian cancer	0.000575	0.0154	CbGeAlD
Trazodone—HTR2A—epithelium—ovarian cancer	0.000546	0.0146	CbGeAlD
Trazodone—ADRA2A—gonad—ovarian cancer	0.000534	0.0143	CbGeAlD
Trazodone—ADRA2A—uterus—ovarian cancer	0.00053	0.0142	CbGeAlD
Trazodone—ORM1—lymph node—ovarian cancer	0.000526	0.0141	CbGeAlD
Trazodone—HRH1—female reproductive system—ovarian cancer	0.000485	0.013	CbGeAlD
Trazodone—ADRA2A—female reproductive system—ovarian cancer	0.000477	0.0128	CbGeAlD
Trazodone—ABCB1—myometrium—ovarian cancer	0.000455	0.0122	CbGeAlD
Trazodone—CYP3A5—female gonad—ovarian cancer	0.000455	0.0122	CbGeAlD
Trazodone—HTR2A—gonad—ovarian cancer	0.000454	0.0122	CbGeAlD
Trazodone—CYP3A5—vagina—ovarian cancer	0.000452	0.0121	CbGeAlD
Trazodone—HTR2B—lymph node—ovarian cancer	0.000444	0.0119	CbGeAlD
Trazodone—HRH1—female gonad—ovarian cancer	0.000442	0.0118	CbGeAlD
Trazodone—HRH1—vagina—ovarian cancer	0.000439	0.0118	CbGeAlD
Trazodone—ABCB1—embryo—ovarian cancer	0.000438	0.0118	CbGeAlD
Trazodone—ADRA2A—female gonad—ovarian cancer	0.000434	0.0116	CbGeAlD
Trazodone—ADRA2A—vagina—ovarian cancer	0.000431	0.0116	CbGeAlD
Trazodone—HTR2A—female reproductive system—ovarian cancer	0.000405	0.0109	CbGeAlD
Trazodone—HRH1—testis—ovarian cancer	0.000392	0.0105	CbGeAlD
Trazodone—ADRA2A—testis—ovarian cancer	0.000385	0.0103	CbGeAlD
Trazodone—CYP3A4—female reproductive system—ovarian cancer	0.000375	0.0101	CbGeAlD
Trazodone—CYP2D6—female reproductive system—ovarian cancer	0.000369	0.00991	CbGeAlD
Trazodone—HTR2A—vagina—ovarian cancer	0.000367	0.00984	CbGeAlD
Trazodone—ABCB1—epithelium—ovarian cancer	0.000357	0.00959	CbGeAlD
Trazodone—ABCB1—uterine cervix—ovarian cancer	0.000354	0.00951	CbGeAlD
Trazodone—ABCB1—decidua—ovarian cancer	0.000338	0.00906	CbGeAlD
Trazodone—CYP2D6—female gonad—ovarian cancer	0.000336	0.00901	CbGeAlD
Trazodone—HTR2A—testis—ovarian cancer	0.000327	0.00878	CbGeAlD
Trazodone—ABCB1—endometrium—ovarian cancer	0.000321	0.0086	CbGeAlD
Trazodone—Clozapine—CYP1B1—ovarian cancer	0.000299	0.238	CrCbGaD
Trazodone—CYP2D6—testis—ovarian cancer	0.000298	0.008	CbGeAlD
Trazodone—ABCB1—gonad—ovarian cancer	0.000297	0.00798	CbGeAlD
Trazodone—ABCB1—uterus—ovarian cancer	0.000295	0.00793	CbGeAlD
Trazodone—HRH1—lymph node—ovarian cancer	0.000284	0.00762	CbGeAlD
Trazodone—ADRA2A—lymph node—ovarian cancer	0.000279	0.00748	CbGeAlD
Trazodone—ABCB1—female reproductive system—ovarian cancer	0.000266	0.00713	CbGeAlD
Trazodone—ABCB1—bone marrow—ovarian cancer	0.000251	0.00673	CbGeAlD
Trazodone—Malaise—Paclitaxel—ovarian cancer	0.000248	0.00124	CcSEcCtD
Trazodone—Vertigo—Paclitaxel—ovarian cancer	0.000247	0.00124	CcSEcCtD
Trazodone—Syncope—Paclitaxel—ovarian cancer	0.000247	0.00123	CcSEcCtD
Trazodone—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000247	0.00123	CcSEcCtD
Trazodone—Lethargy—Doxorubicin—ovarian cancer	0.000247	0.00123	CcSEcCtD
Trazodone—Rash—Topotecan—ovarian cancer	0.000246	0.00123	CcSEcCtD
Trazodone—Hypersensitivity—Vinorelbine—ovarian cancer	0.000246	0.00123	CcSEcCtD
Trazodone—Dermatitis—Topotecan—ovarian cancer	0.000246	0.00123	CcSEcCtD
Trazodone—Ataxia—Epirubicin—ovarian cancer	0.000246	0.00123	CcSEcCtD
Trazodone—Headache—Topotecan—ovarian cancer	0.000245	0.00122	CcSEcCtD
Trazodone—Palpitations—Paclitaxel—ovarian cancer	0.000243	0.00122	CcSEcCtD
Trazodone—Vomiting—Melphalan—ovarian cancer	0.000243	0.00121	CcSEcCtD
Trazodone—Hyponatraemia—Doxorubicin—ovarian cancer	0.000243	0.00121	CcSEcCtD
Trazodone—Loss of consciousness—Paclitaxel—ovarian cancer	0.000242	0.00121	CcSEcCtD
Trazodone—Diplopia—Doxorubicin—ovarian cancer	0.000242	0.00121	CcSEcCtD
Trazodone—ABCB1—female gonad—ovarian cancer	0.000242	0.00648	CbGeAlD
Trazodone—Rash—Melphalan—ovarian cancer	0.000241	0.0012	CcSEcCtD
Trazodone—Dermatitis—Melphalan—ovarian cancer	0.000241	0.0012	CcSEcCtD
Trazodone—Chills—Docetaxel—ovarian cancer	0.000241	0.0012	CcSEcCtD
Trazodone—ABCB1—vagina—ovarian cancer	0.00024	0.00645	CbGeAlD
Trazodone—Asthenia—Vinorelbine—ovarian cancer	0.00024	0.0012	CcSEcCtD
Trazodone—Arrhythmia—Docetaxel—ovarian cancer	0.00024	0.0012	CcSEcCtD
Trazodone—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000239	0.00119	CcSEcCtD
Trazodone—Migraine—Doxorubicin—ovarian cancer	0.000238	0.00119	CcSEcCtD
Trazodone—Hypertension—Paclitaxel—ovarian cancer	0.000238	0.00119	CcSEcCtD
Trazodone—Alopecia—Docetaxel—ovarian cancer	0.000237	0.00118	CcSEcCtD
Trazodone—Pruritus—Vinorelbine—ovarian cancer	0.000236	0.00118	CcSEcCtD
Trazodone—Chest pain—Paclitaxel—ovarian cancer	0.000235	0.00117	CcSEcCtD
Trazodone—Arthralgia—Paclitaxel—ovarian cancer	0.000235	0.00117	CcSEcCtD
Trazodone—Myalgia—Paclitaxel—ovarian cancer	0.000235	0.00117	CcSEcCtD
Trazodone—Anxiety—Paclitaxel—ovarian cancer	0.000234	0.00117	CcSEcCtD
Trazodone—Nausea—Topotecan—ovarian cancer	0.000232	0.00116	CcSEcCtD
Trazodone—Discomfort—Paclitaxel—ovarian cancer	0.000232	0.00116	CcSEcCtD
Trazodone—Cardiac arrest—Doxorubicin—ovarian cancer	0.00023	0.00115	CcSEcCtD
Trazodone—Dry mouth—Paclitaxel—ovarian cancer	0.000229	0.00115	CcSEcCtD
Trazodone—Diarrhoea—Vinorelbine—ovarian cancer	0.000229	0.00114	CcSEcCtD
Trazodone—Dysgeusia—Docetaxel—ovarian cancer	0.000229	0.00114	CcSEcCtD
Trazodone—Ataxia—Doxorubicin—ovarian cancer	0.000228	0.00114	CcSEcCtD
Trazodone—Nausea—Melphalan—ovarian cancer	0.000227	0.00113	CcSEcCtD
Trazodone—Confusional state—Paclitaxel—ovarian cancer	0.000227	0.00113	CcSEcCtD
Trazodone—Back pain—Docetaxel—ovarian cancer	0.000226	0.00113	CcSEcCtD
Trazodone—Oedema—Paclitaxel—ovarian cancer	0.000225	0.00112	CcSEcCtD
Trazodone—Shock—Paclitaxel—ovarian cancer	0.000221	0.0011	CcSEcCtD
Trazodone—Dizziness—Vinorelbine—ovarian cancer	0.000221	0.0011	CcSEcCtD
Trazodone—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000221	0.0011	CcSEcCtD
Trazodone—Tachycardia—Paclitaxel—ovarian cancer	0.000219	0.0011	CcSEcCtD
Trazodone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000217	0.00109	CcSEcCtD
Trazodone—Anaemia—Docetaxel—ovarian cancer	0.000216	0.00108	CcSEcCtD
Trazodone—ABCB1—testis—ovarian cancer	0.000214	0.00575	CbGeAlD
Trazodone—Anorexia—Paclitaxel—ovarian cancer	0.000214	0.00107	CcSEcCtD
Trazodone—Vomiting—Vinorelbine—ovarian cancer	0.000213	0.00106	CcSEcCtD
Trazodone—Rash—Vinorelbine—ovarian cancer	0.000211	0.00105	CcSEcCtD
Trazodone—Dermatitis—Vinorelbine—ovarian cancer	0.000211	0.00105	CcSEcCtD
Trazodone—Hypotension—Paclitaxel—ovarian cancer	0.00021	0.00105	CcSEcCtD
Trazodone—Headache—Vinorelbine—ovarian cancer	0.000209	0.00105	CcSEcCtD
Trazodone—Syncope—Docetaxel—ovarian cancer	0.000209	0.00105	CcSEcCtD
Trazodone—Pollakiuria—Epirubicin—ovarian cancer	0.000209	0.00104	CcSEcCtD
Trazodone—Domperidone—ABCB1—ovarian cancer	0.000206	0.165	CrCbGaD
Trazodone—Palpitations—Docetaxel—ovarian cancer	0.000206	0.00103	CcSEcCtD
Trazodone—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000206	0.00103	CcSEcCtD
Trazodone—Weight increased—Epirubicin—ovarian cancer	0.000206	0.00103	CcSEcCtD
Trazodone—Loss of consciousness—Docetaxel—ovarian cancer	0.000205	0.00102	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000205	0.00102	CcSEcCtD
Trazodone—Weight decreased—Epirubicin—ovarian cancer	0.000204	0.00102	CcSEcCtD
Trazodone—Insomnia—Paclitaxel—ovarian cancer	0.000203	0.00102	CcSEcCtD
Trazodone—Paraesthesia—Paclitaxel—ovarian cancer	0.000202	0.00101	CcSEcCtD
Trazodone—Hypertension—Docetaxel—ovarian cancer	0.000202	0.00101	CcSEcCtD
Trazodone—Drowsiness—Epirubicin—ovarian cancer	0.000202	0.00101	CcSEcCtD
Trazodone—Dyspnoea—Paclitaxel—ovarian cancer	0.0002	0.001	CcSEcCtD
Trazodone—Somnolence—Paclitaxel—ovarian cancer	0.0002	0.000998	CcSEcCtD
Trazodone—Myalgia—Docetaxel—ovarian cancer	0.000199	0.000993	CcSEcCtD
Trazodone—Chest pain—Docetaxel—ovarian cancer	0.000199	0.000993	CcSEcCtD
Trazodone—Arthralgia—Docetaxel—ovarian cancer	0.000199	0.000993	CcSEcCtD
Trazodone—Nausea—Vinorelbine—ovarian cancer	0.000199	0.000991	CcSEcCtD
Trazodone—Jaundice—Epirubicin—ovarian cancer	0.000196	0.000981	CcSEcCtD
Trazodone—Decreased appetite—Paclitaxel—ovarian cancer	0.000195	0.000976	CcSEcCtD
Trazodone—Dry mouth—Docetaxel—ovarian cancer	0.000194	0.000971	CcSEcCtD
Trazodone—Fatigue—Paclitaxel—ovarian cancer	0.000194	0.000968	CcSEcCtD
Trazodone—Sweating—Epirubicin—ovarian cancer	0.000193	0.000965	CcSEcCtD
Trazodone—Pollakiuria—Doxorubicin—ovarian cancer	0.000193	0.000965	CcSEcCtD
Trazodone—Constipation—Paclitaxel—ovarian cancer	0.000192	0.00096	CcSEcCtD
Trazodone—Pain—Paclitaxel—ovarian cancer	0.000192	0.00096	CcSEcCtD
Trazodone—Haematuria—Epirubicin—ovarian cancer	0.000192	0.00096	CcSEcCtD
Trazodone—Confusional state—Docetaxel—ovarian cancer	0.000192	0.000959	CcSEcCtD
Trazodone—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000191	0.000953	CcSEcCtD
Trazodone—Oedema—Docetaxel—ovarian cancer	0.000191	0.000952	CcSEcCtD
Trazodone—Weight increased—Doxorubicin—ovarian cancer	0.00019	0.00095	CcSEcCtD
Trazodone—Weight decreased—Doxorubicin—ovarian cancer	0.000189	0.000945	CcSEcCtD
Trazodone—Shock—Docetaxel—ovarian cancer	0.000187	0.000936	CcSEcCtD
Trazodone—Drowsiness—Doxorubicin—ovarian cancer	0.000186	0.000931	CcSEcCtD
Trazodone—Tachycardia—Docetaxel—ovarian cancer	0.000186	0.000929	CcSEcCtD
Trazodone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000185	0.000925	CcSEcCtD
Trazodone—Bradycardia—Epirubicin—ovarian cancer	0.000184	0.00092	CcSEcCtD
Trazodone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000184	0.000918	CcSEcCtD
Trazodone—Jaundice—Doxorubicin—ovarian cancer	0.000182	0.000908	CcSEcCtD
Trazodone—Anorexia—Docetaxel—ovarian cancer	0.000182	0.000907	CcSEcCtD
Trazodone—Hypoaesthesia—Epirubicin—ovarian cancer	0.00018	0.000899	CcSEcCtD
Trazodone—Sweating—Doxorubicin—ovarian cancer	0.000179	0.000893	CcSEcCtD
Trazodone—Urticaria—Paclitaxel—ovarian cancer	0.000179	0.000892	CcSEcCtD
Trazodone—Hypotension—Docetaxel—ovarian cancer	0.000178	0.000889	CcSEcCtD
Trazodone—Haematuria—Doxorubicin—ovarian cancer	0.000178	0.000888	CcSEcCtD
Trazodone—Abdominal pain—Paclitaxel—ovarian cancer	0.000178	0.000888	CcSEcCtD
Trazodone—Body temperature increased—Paclitaxel—ovarian cancer	0.000178	0.000888	CcSEcCtD
Trazodone—Visual impairment—Epirubicin—ovarian cancer	0.000174	0.000871	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000174	0.000867	CcSEcCtD
Trazodone—Insomnia—Docetaxel—ovarian cancer	0.000172	0.000861	CcSEcCtD
Trazodone—Nefazodone—ABCB1—ovarian cancer	0.000171	0.137	CrCbGaD
Trazodone—Paraesthesia—Docetaxel—ovarian cancer	0.000171	0.000854	CcSEcCtD
Trazodone—Bradycardia—Doxorubicin—ovarian cancer	0.00017	0.000851	CcSEcCtD
Trazodone—Dyspnoea—Docetaxel—ovarian cancer	0.00017	0.000848	CcSEcCtD
Trazodone—Somnolence—Docetaxel—ovarian cancer	0.000169	0.000846	CcSEcCtD
Trazodone—Tinnitus—Epirubicin—ovarian cancer	0.000169	0.000842	CcSEcCtD
Trazodone—Flushing—Epirubicin—ovarian cancer	0.000168	0.000838	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000167	0.000832	CcSEcCtD
Trazodone—Decreased appetite—Docetaxel—ovarian cancer	0.000166	0.000827	CcSEcCtD
Trazodone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000166	0.000827	CcSEcCtD
Trazodone—Fatigue—Docetaxel—ovarian cancer	0.000164	0.00082	CcSEcCtD
Trazodone—Pain—Docetaxel—ovarian cancer	0.000163	0.000814	CcSEcCtD
Trazodone—Constipation—Docetaxel—ovarian cancer	0.000163	0.000814	CcSEcCtD
Trazodone—Chills—Epirubicin—ovarian cancer	0.000162	0.000811	CcSEcCtD
Trazodone—Arrhythmia—Epirubicin—ovarian cancer	0.000162	0.000807	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—ovarian cancer	0.000161	0.000806	CcSEcCtD
Trazodone—Asthenia—Paclitaxel—ovarian cancer	0.000161	0.000805	CcSEcCtD
Trazodone—Alopecia—Epirubicin—ovarian cancer	0.00016	0.000798	CcSEcCtD
Trazodone—Aripiprazole—ABCB1—ovarian cancer	0.000159	0.127	CrCbGaD
Trazodone—Pruritus—Paclitaxel—ovarian cancer	0.000159	0.000794	CcSEcCtD
Trazodone—Feeling abnormal—Docetaxel—ovarian cancer	0.000157	0.000784	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—ovarian cancer	0.000156	0.000779	CcSEcCtD
Trazodone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000156	0.000778	CcSEcCtD
Trazodone—ABCB1—lymph node—ovarian cancer	0.000155	0.00417	CbGeAlD
Trazodone—Flushing—Doxorubicin—ovarian cancer	0.000155	0.000776	CcSEcCtD
Trazodone—Flatulence—Epirubicin—ovarian cancer	0.000155	0.000775	CcSEcCtD
Trazodone—Tension—Epirubicin—ovarian cancer	0.000155	0.000772	CcSEcCtD
Trazodone—Dysgeusia—Epirubicin—ovarian cancer	0.000154	0.00077	CcSEcCtD
Trazodone—Diarrhoea—Paclitaxel—ovarian cancer	0.000154	0.000768	CcSEcCtD
Trazodone—Nervousness—Epirubicin—ovarian cancer	0.000153	0.000764	CcSEcCtD
Trazodone—Back pain—Epirubicin—ovarian cancer	0.000152	0.000761	CcSEcCtD
Trazodone—Abdominal pain—Docetaxel—ovarian cancer	0.000151	0.000752	CcSEcCtD
Trazodone—Body temperature increased—Docetaxel—ovarian cancer	0.000151	0.000752	CcSEcCtD
Trazodone—Chills—Doxorubicin—ovarian cancer	0.00015	0.00075	CcSEcCtD
Trazodone—Arrhythmia—Doxorubicin—ovarian cancer	0.00015	0.000747	CcSEcCtD
Trazodone—Dizziness—Paclitaxel—ovarian cancer	0.000149	0.000742	CcSEcCtD
Trazodone—Vision blurred—Epirubicin—ovarian cancer	0.000148	0.000741	CcSEcCtD
Trazodone—Alopecia—Doxorubicin—ovarian cancer	0.000148	0.000739	CcSEcCtD
Trazodone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000146	0.00073	CcSEcCtD
Trazodone—Anaemia—Epirubicin—ovarian cancer	0.000146	0.000727	CcSEcCtD
Trazodone—Agitation—Epirubicin—ovarian cancer	0.000145	0.000723	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—ovarian cancer	0.000144	0.000717	CcSEcCtD
Trazodone—Tension—Doxorubicin—ovarian cancer	0.000143	0.000714	CcSEcCtD
Trazodone—Vomiting—Paclitaxel—ovarian cancer	0.000143	0.000714	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—ovarian cancer	0.000143	0.000713	CcSEcCtD
Trazodone—Malaise—Epirubicin—ovarian cancer	0.000142	0.000709	CcSEcCtD
Trazodone—Rash—Paclitaxel—ovarian cancer	0.000142	0.000708	CcSEcCtD
Trazodone—Dermatitis—Paclitaxel—ovarian cancer	0.000142	0.000707	CcSEcCtD
Trazodone—Nervousness—Doxorubicin—ovarian cancer	0.000142	0.000707	CcSEcCtD
Trazodone—Vertigo—Epirubicin—ovarian cancer	0.000141	0.000707	CcSEcCtD
Trazodone—Syncope—Epirubicin—ovarian cancer	0.000141	0.000705	CcSEcCtD
Trazodone—Back pain—Doxorubicin—ovarian cancer	0.000141	0.000704	CcSEcCtD
Trazodone—Headache—Paclitaxel—ovarian cancer	0.000141	0.000703	CcSEcCtD
Trazodone—Hypersensitivity—Docetaxel—ovarian cancer	0.00014	0.000701	CcSEcCtD
Trazodone—Palpitations—Epirubicin—ovarian cancer	0.000139	0.000695	CcSEcCtD
Trazodone—Loss of consciousness—Epirubicin—ovarian cancer	0.000138	0.000691	CcSEcCtD
Trazodone—Vision blurred—Doxorubicin—ovarian cancer	0.000137	0.000686	CcSEcCtD
Trazodone—Asthenia—Docetaxel—ovarian cancer	0.000137	0.000683	CcSEcCtD
Trazodone—Hypertension—Epirubicin—ovarian cancer	0.000136	0.000679	CcSEcCtD
Trazodone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000135	0.000675	CcSEcCtD
Trazodone—Pruritus—Docetaxel—ovarian cancer	0.000135	0.000673	CcSEcCtD
Trazodone—Anaemia—Doxorubicin—ovarian cancer	0.000135	0.000673	CcSEcCtD
Trazodone—Myalgia—Epirubicin—ovarian cancer	0.000134	0.00067	CcSEcCtD
Trazodone—Arthralgia—Epirubicin—ovarian cancer	0.000134	0.00067	CcSEcCtD
Trazodone—Chest pain—Epirubicin—ovarian cancer	0.000134	0.00067	CcSEcCtD
Trazodone—Agitation—Doxorubicin—ovarian cancer	0.000134	0.000669	CcSEcCtD
Trazodone—Anxiety—Epirubicin—ovarian cancer	0.000134	0.000667	CcSEcCtD
Trazodone—Nausea—Paclitaxel—ovarian cancer	0.000134	0.000667	CcSEcCtD
Trazodone—Discomfort—Epirubicin—ovarian cancer	0.000132	0.000662	CcSEcCtD
Trazodone—Malaise—Doxorubicin—ovarian cancer	0.000131	0.000656	CcSEcCtD
Trazodone—Dry mouth—Epirubicin—ovarian cancer	0.000131	0.000655	CcSEcCtD
Trazodone—Vertigo—Doxorubicin—ovarian cancer	0.000131	0.000654	CcSEcCtD
Trazodone—Syncope—Doxorubicin—ovarian cancer	0.000131	0.000653	CcSEcCtD
Trazodone—Diarrhoea—Docetaxel—ovarian cancer	0.00013	0.000651	CcSEcCtD
Trazodone—Confusional state—Epirubicin—ovarian cancer	0.00013	0.000647	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—ovarian cancer	0.000129	0.000643	CcSEcCtD
Trazodone—Oedema—Epirubicin—ovarian cancer	0.000129	0.000642	CcSEcCtD
Trazodone—Fluphenazine—ABCB1—ovarian cancer	0.000128	0.103	CrCbGaD
Trazodone—Loss of consciousness—Doxorubicin—ovarian cancer	0.000128	0.00064	CcSEcCtD
Trazodone—Shock—Epirubicin—ovarian cancer	0.000126	0.000631	CcSEcCtD
Trazodone—Dizziness—Docetaxel—ovarian cancer	0.000126	0.000629	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—ovarian cancer	0.000126	0.000628	CcSEcCtD
Trazodone—Tachycardia—Epirubicin—ovarian cancer	0.000125	0.000626	CcSEcCtD
Trazodone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000124	0.00062	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—ovarian cancer	0.000124	0.00062	CcSEcCtD
Trazodone—Myalgia—Doxorubicin—ovarian cancer	0.000124	0.00062	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—ovarian cancer	0.000124	0.00062	CcSEcCtD
Trazodone—Anxiety—Doxorubicin—ovarian cancer	0.000124	0.000617	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—ovarian cancer	0.000123	0.000612	CcSEcCtD
Trazodone—Anorexia—Epirubicin—ovarian cancer	0.000123	0.000612	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—ovarian cancer	0.000121	0.000606	CcSEcCtD
Trazodone—Vomiting—Docetaxel—ovarian cancer	0.000121	0.000605	CcSEcCtD
Trazodone—Rash—Docetaxel—ovarian cancer	0.00012	0.0006	CcSEcCtD
Trazodone—Hypotension—Epirubicin—ovarian cancer	0.00012	0.0006	CcSEcCtD
Trazodone—Dermatitis—Docetaxel—ovarian cancer	0.00012	0.000599	CcSEcCtD
Trazodone—Confusional state—Doxorubicin—ovarian cancer	0.00012	0.000599	CcSEcCtD
Trazodone—Headache—Docetaxel—ovarian cancer	0.000119	0.000596	CcSEcCtD
Trazodone—Oedema—Doxorubicin—ovarian cancer	0.000119	0.000594	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000117	0.000585	CcSEcCtD
Trazodone—Shock—Doxorubicin—ovarian cancer	0.000117	0.000584	CcSEcCtD
Trazodone—Insomnia—Epirubicin—ovarian cancer	0.000116	0.000581	CcSEcCtD
Trazodone—Tachycardia—Doxorubicin—ovarian cancer	0.000116	0.00058	CcSEcCtD
Trazodone—Paraesthesia—Epirubicin—ovarian cancer	0.000115	0.000576	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000115	0.000574	CcSEcCtD
Trazodone—Dyspnoea—Epirubicin—ovarian cancer	0.000115	0.000572	CcSEcCtD
Trazodone—Somnolence—Epirubicin—ovarian cancer	0.000114	0.000571	CcSEcCtD
Trazodone—Anorexia—Doxorubicin—ovarian cancer	0.000113	0.000566	CcSEcCtD
Trazodone—Nausea—Docetaxel—ovarian cancer	0.000113	0.000565	CcSEcCtD
Trazodone—Decreased appetite—Epirubicin—ovarian cancer	0.000112	0.000558	CcSEcCtD
Trazodone—Hypotension—Doxorubicin—ovarian cancer	0.000111	0.000555	CcSEcCtD
Trazodone—Fatigue—Epirubicin—ovarian cancer	0.000111	0.000553	CcSEcCtD
Trazodone—Pain—Epirubicin—ovarian cancer	0.00011	0.000549	CcSEcCtD
Trazodone—Constipation—Epirubicin—ovarian cancer	0.00011	0.000549	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000108	0.000541	CcSEcCtD
Trazodone—Insomnia—Doxorubicin—ovarian cancer	0.000108	0.000537	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—ovarian cancer	0.000107	0.000533	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—ovarian cancer	0.000106	0.000529	CcSEcCtD
Trazodone—Feeling abnormal—Epirubicin—ovarian cancer	0.000106	0.000529	CcSEcCtD
Trazodone—Somnolence—Doxorubicin—ovarian cancer	0.000106	0.000528	CcSEcCtD
Trazodone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000105	0.000525	CcSEcCtD
Trazodone—Decreased appetite—Doxorubicin—ovarian cancer	0.000103	0.000516	CcSEcCtD
Trazodone—Trifluoperazine—ABCB1—ovarian cancer	0.000103	0.082	CrCbGaD
Trazodone—Fatigue—Doxorubicin—ovarian cancer	0.000103	0.000512	CcSEcCtD
Trazodone—Urticaria—Epirubicin—ovarian cancer	0.000102	0.00051	CcSEcCtD
Trazodone—Pain—Doxorubicin—ovarian cancer	0.000102	0.000508	CcSEcCtD
Trazodone—Constipation—Doxorubicin—ovarian cancer	0.000102	0.000508	CcSEcCtD
Trazodone—Abdominal pain—Epirubicin—ovarian cancer	0.000102	0.000507	CcSEcCtD
Trazodone—Body temperature increased—Epirubicin—ovarian cancer	0.000102	0.000507	CcSEcCtD
Trazodone—Quetiapine—ABCB1—ovarian cancer	9.96e-05	0.0795	CrCbGaD
Trazodone—Feeling abnormal—Doxorubicin—ovarian cancer	9.8e-05	0.000489	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—ovarian cancer	9.72e-05	0.000486	CcSEcCtD
Trazodone—Hypersensitivity—Epirubicin—ovarian cancer	9.47e-05	0.000473	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—ovarian cancer	9.45e-05	0.000472	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—ovarian cancer	9.4e-05	0.000469	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—ovarian cancer	9.4e-05	0.000469	CcSEcCtD
Trazodone—Asthenia—Epirubicin—ovarian cancer	9.22e-05	0.000461	CcSEcCtD
Trazodone—Pruritus—Epirubicin—ovarian cancer	9.09e-05	0.000454	CcSEcCtD
Trazodone—Diarrhoea—Epirubicin—ovarian cancer	8.79e-05	0.000439	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—ovarian cancer	8.76e-05	0.000438	CcSEcCtD
Trazodone—Clozapine—ABCB1—ovarian cancer	8.57e-05	0.0684	CrCbGaD
Trazodone—Asthenia—Doxorubicin—ovarian cancer	8.53e-05	0.000426	CcSEcCtD
Trazodone—Dizziness—Epirubicin—ovarian cancer	8.5e-05	0.000424	CcSEcCtD
Trazodone—Pruritus—Doxorubicin—ovarian cancer	8.41e-05	0.00042	CcSEcCtD
Trazodone—Vomiting—Epirubicin—ovarian cancer	8.17e-05	0.000408	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—ovarian cancer	8.14e-05	0.000406	CcSEcCtD
Trazodone—Rash—Epirubicin—ovarian cancer	8.1e-05	0.000405	CcSEcCtD
Trazodone—Dermatitis—Epirubicin—ovarian cancer	8.1e-05	0.000404	CcSEcCtD
Trazodone—Headache—Epirubicin—ovarian cancer	8.05e-05	0.000402	CcSEcCtD
Trazodone—Dizziness—Doxorubicin—ovarian cancer	7.86e-05	0.000393	CcSEcCtD
Trazodone—Nausea—Epirubicin—ovarian cancer	7.63e-05	0.000381	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—ovarian cancer	7.56e-05	0.000378	CcSEcCtD
Trazodone—Rash—Doxorubicin—ovarian cancer	7.5e-05	0.000374	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—ovarian cancer	7.49e-05	0.000374	CcSEcCtD
Trazodone—Headache—Doxorubicin—ovarian cancer	7.45e-05	0.000372	CcSEcCtD
Trazodone—Nausea—Doxorubicin—ovarian cancer	7.06e-05	0.000353	CcSEcCtD
